TABLE 3.
Group | No. of infected mice | No. (%) of mice that survived | Colony counts/organ
|
|
---|---|---|---|---|
Liver | Kidney | |||
L-nystatin, 5 mg/kg (days 1, 2, 4, and 7) | 20 | 18 (90) | 1b | <1c |
L-nystatin, 1 mg/kg (days 1, 2, 4, and 7) | 10 | 5 (50) | 35 | 63 |
L-amphotericin, 5 mg/kg (days 1, 2, 4, and 7) | 20 | 14 (70) | 7 | 15 |
L-amphotericin, 1 mg/kg (days 1, 2, 4, and 7) | 20 | 4 (20) | 72 | 211 |
ABLC, 5 mg/kg (days 1 to 7) | 20 | 10 (50) | 19 | 22 |
ABLC, 1 mg/kg (days 1 to 7) | 20 | 3 (15) | 114 | 245 |
Amphotericin B, 5 mg/kg (days 1, 2, 4, and 7) | 20 | 11 (55) | 14 | 13 |
Amphotericin B, 1 mg/kg (days 1, 2, 4, and 7) | 10 | 5 (50) | 54 | 68 |
Controlsd | 70 | 0 (0) |
Results are for data pooled from all experiments (except the pilot experiment).
P = 0.0032 for L-nystatin at 5 mg/kg versus all doses of all drugs.
P = <0.0001 for L-nystatin at 5 mg/kg versus all doses of all drugs.
Five percent dextrose or empty liposomes.